Position in CGEM
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,202,788
-$13,711,757 QoQ
Shares Held
66,051
-93.7% QoQ
Ownership
0.103%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 183 holders
Holding Since
Jun 2021
15 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CGEM Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026MARSHALL WACE, LLP holds $3,055,517,440 across 267 Biotechnology names. CGEM ranks #172 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
543,897 | $270,169,956 | |
| 2 | INCY |
Incyte Corp
|
1,310,154 | $148,519,056 | |
| 3 | RPRX |
Royalty Pharma plc
|
2,450,669 | $137,409,009 | |
| 4 | SYRE |
Spyre Therapeutics, Inc.
|
991,693 | $88,042,503 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
259,799 | $78,207,292 | |
| 6 | TVTX |
Travere Therapeutics, Inc.
|
1,333,207 | $75,739,488 | |
| 7 | MANE |
Veradermics, Inc
|
585,560 | $71,988,746 | |
| 8 | DFTX |
Definium Therapeutics, Inc.
|
1,298,946 | $61,102,419 |
All Filings in CGEM
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,202,788 | 66,051 | Shares | Other | 2026-08-13 | |
| 2026-03-31 | $14,914,545 | 1,049,581 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $4,288,615 | 414,359 | Shares | Other | 2026-02-13 | |
| 2025-09-30 | $1,751,971 | 295,442 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $4,718,154 | 626,581 | Shares | Other | 2025-08-13 | |
| 2025-03-31 | $4,299,752 | 567,999 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $7,937,620 | 651,693 | Shares | Other | 2025-02-13 | |
| 2024-09-30 | $17,640,009 | 1,053,764 | Shares | Other | 2024-11-14 | |
| 2024-06-30 | $20,649,605 | 1,184,037 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $801,629 | 47,044 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $340,081 | 33,374 | Shares | Other | 2024-02-14 | |
| 2023-06-30 | $116,606 | 10,837 | Shares | Other | 2023-08-14 | |
| 2022-09-30 | $520,184 | 40,576 | Shares | Other | 2022-11-14 | |
| 2022-06-30 | $552,836 | 43,123 | Shares | Other | 2022-08-15 | |
| 2021-06-30 | $1,929,988 | 74,951 | Shares | Sole | 2021-08-13 | |
| No filing history on record for this holder in this stock. | ||||||